Delivery Order SPE2DE21D0017-SPE2D625F1RPS
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $3,360 fixed-price delivery order with economic price adjustment on July 22, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strip A2 Qual Detect Mobile Test delivery order, is scheduled for ultimate completion on July 23, 2025, and will be performed in Lockhart, Florida. No set-aside designation was applied to this award, indicating full and open...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment for COVID-19 test kits on August 7, 2025, with an ultimate completion date of August 18, 2025. The contract, issued without set-aside designation, is funded by the Defense Logistics Agency Medical Supply Chain and specifies performance at the contractor's facility in Lockhart, Florida. This delivery order represents a continuation of...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,360.00 by the Defense Logistics Agency Medical Supply Chain for a kit identifying now strip A2 qualitative detect mobile test, with an ultimate completion date of July 22, 2025. The contract was awarded under a fixed-price arrangement with economic price adjustment provisions and will be performed in Lockhart, Florida. No set-aside designation was applied to this award,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $15,000 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on August 7, 2025, for ID NOW flu diagnostic testing products. The contract, which carries no set-aside designation, indicates open competition and is scheduled for ultimate completion on August 14, 2025. Performance will occur at the vendor's location in Lockhart, Florida. This...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $10,200 delivery order on July 24, 2025, for ID NOW flu tests under contract 4568885102. This fixed-price delivery order with economic price adjustment has an ultimate completion date of July 31, 2025, and will be performed in Lockhart, Florida. The award was made without a set-aside designation, indicating open competition. The funding agency is the Defense Logistics Agency (DLA) Medical Supply Chain,...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a fixed-price delivery order valued at $6,720.00 from the Defense Logistics Agency (DLA) Medical Supply Chain on August 22, 2025, for ID NOW Strep diagnostic testing supplies. The contract, which is not set-aside and awarded under open competition, is scheduled for completion by August 29, 2025, and will be performed in Lockhart, Florida. This delivery order represents a continuation of the company's...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostic equipment and testing supplies, has been awarded a delivery order valued at $6,720.00 for ID NOW Strep tests by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 30, 2025, with an ultimate completion date of August 6, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, indicating...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order valued at $1,407.07 for BinaxNOW COVID-19 antigen test cards. This fixed-price contract with economic price adjustment was awarded on July 25, 2025, with an ultimate completion date of August 15, 2025, and will be performed in Lockhart, Florida. The award was issued without a set-aside designation, indicating open competition. Funding is provided through the Defense Logistics Agency...
- This is a $3,360.00 fixed-price delivery order with economic price adjustment awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the supply of KIT ID NOW STRP A2 QUAL DTCT MCBLTST 24, a medical diagnostic product. This order is part of a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement (BPA), that Abbott Rapid DX North America LLC holds with the DLA and...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D625F1RPSDelivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order valued at $3,360.00 for ID NOW Strip A2 Qual Detect Microlab Test kits on August 22, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and does not include a set-aside designation, indicating competition was conducted on an unrestricted basis. Performance will be completed in Lockhart, Florida, with an ultimate completion date of August 26, 2025. The funding source is the Medical Supply Chain division within the Defense Logistics Agency, which procures critical medical diagnostic and testing supplies for Department of Defense healthcare facilities and related federal medical operations. This delivery order represents a task order issued under Abbott Rapid DX North America LLC's existing indefinite delivery contract vehicles with the Defense Logistics Agency. The award aligns with the company's established role as a primary federal supplier of point-of-care diagnostic testing products, particularly ID NOW rapid diagnostic tests for influenza and streptococcal detection. The vendor's historical contract performance demonstrates consistent capability in supplying medical diagnostic equipment and testing supplies to federal healthcare agencies, with prior awards for COVID-19 antigen test kits, control kits, and specialized diagnostic platforms supporting ongoing federal healthcare testing requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/22/25 |